Apeloa Pharmaceutical Hits Day High with Strong 3.44% Intraday Surge

Apeloa Pharmaceutical Co., Ltd. has shown significant activity today, with the stock rising by 3.44% as of September 25, 2025. The stock reached an intraday high of CNY 16.96, reflecting a notable performance in the pharmaceuticals and biotechnology sector.
In comparison to the broader market, Apeloa's one-day performance outpaced the China Shanghai Composite, which increased by 0.83%. However, over the past week, the stock has seen a slight decline of 0.72%, contrasting with the composite's marginal drop of 0.59%.

Looking at longer-term metrics, Apeloa has delivered a 15.03% increase over the past year, although this lags behind the China Shanghai Composite's impressive 34.6% gain. Year-to-date, the stock has risen by 1.66%, while the composite has performed better at 14.97%.

With a market capitalization of CNY 18,513 million, Apeloa maintains a P/E ratio of 19.00 and a dividend yield of 4.48%. The company's return on equity stands at 14.23%, indicating a solid performance relative to its equity base.